A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin

Clinical trial NCT01388335 · COMPLETED

Trial details

NCT number: NCT01388335
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Lymphoma, Malignant

Start date: 2011-08-01
Primary completion: 2012-10-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.